These benefits are crucial in preventing high-altitude-related illnesses (e.g., upper respiratory tract infections) and alleviating symptoms of high-altitude sickness, including gastrointestinal disturbances (nausea, vomiting), neuropsychological symptoms (fatigue, drowsiness), and circulatory issues (headache, dizziness, palpitations, shortness of breath, cyanosis of the lips and fingers, and elevated heart rate)
Retatrutide is currently undergoing clinical trials and is not yet FDA approved, so its availability is limited to research settings
This section also helps explain why the two providers land in different methodology tiers
The biology, in short, is where the next generation of these drugs will be designed
Sunless Tanners and Bronzers.